Treventis attends RESI Nov 2021

Treventis CEO Christopher Barden attended the second of the fall Redefining Early Stage Investments (RESI) conferences (held virtually this year due to COVID-19). This conference is a prominent event for life sciences and medical technology companies looking to raise funds for the next stage of their company development. Treventis was proud to schedule meetings with over a dozen investors and organizations with interest in neurodegenerative and oncology drug development.

#pf-body .pf-caption img.blockImage { margin: 0!important; float: none; } #pf-body a.elementor-icon, #pf-body a.skip-link{display:none!important;} /*#pf-content {max-width:100%!important}*/ #pf-content img.mediumImage, #pf-content figure.mediumImage { margin-left: auto!important; margin-right: auto!important; clear: both!important; float: none!important; display: block!important; }